HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Julia Alejandra Pezuk Selected Research

Urinary Bladder Neoplasms (Bladder Cancer)

7/2013In vitro targeting of Polo-like kinase 1 in bladder carcinoma: comparative effects of four potent inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Julia Alejandra Pezuk Research Topics

Disease

13Neoplasms (Cancer)
01/2021 - 02/2011
5Glioblastoma (Glioblastoma Multiforme)
12/2019 - 09/2013
4Medulloblastoma
12/2019 - 12/2012
2Carcinogenesis
12/2019 - 01/2019
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
11/2018 - 03/2012
2Breast Neoplasms (Breast Cancer)
01/2018 - 10/2017
1Neoplasm Metastasis (Metastasis)
10/2020
1Wilms Tumor (Wilm's Tumor)
12/2019
1Rhabdoid Tumor (Rhabdoid Tumors)
12/2019
1Diffuse Intrinsic Pontine Glioma
12/2019
1Hepatoblastoma
12/2019
1Astrocytoma (Pilocytic Astrocytoma)
12/2019
1Choroid Plexus Neoplasms (Choroid Plexus Tumor)
12/2019
1Central Nervous System Neoplasms
12/2019
1Ependymoma
12/2019
1Neuroblastoma
12/2019
1Retinoblastoma (Glioblastoma, Retinal)
01/2019
1Hematologic Neoplasms (Hematological Malignancy)
11/2018
1Urinary Bladder Neoplasms (Bladder Cancer)
07/2013
1Carcinoma (Carcinomatosis)
07/2013
1Osteosarcoma (Osteogenic Sarcoma)
05/2013
1Meningioma (Meningiomas)
12/2012
1Melanoma (Melanoma, Malignant)
05/2012

Drug/Important Bio-Agent (IBA)

7MicroRNAs (MicroRNA)IBA
01/2021 - 03/2012
4Polo-Like Kinase 1IBA
01/2017 - 05/2012
2Tumor Biomarkers (Tumor Markers)IBA
12/2019 - 11/2018
2BI 6727IBA
01/2018 - 07/2013
2Biological ProductsIBA
01/2018 - 03/2012
2GSK 461364IBA
01/2018 - 07/2013
2Radiation-Sensitizing AgentsIBA
12/2013 - 09/2013
2BI 2536IBA
07/2013 - 05/2012
1Phosphotransferases (Kinase)IBA
10/2020
1TransducinIBA
11/2018
1AntigensIBA
11/2018
1Indicators and Reagents (Reagents)IBA
11/2018
1Co-Repressor ProteinsIBA
11/2018
13- ((dodecylthiocarbonyl)methyl)glutarimideIBA
01/2018
1Drug CombinationsIBA
01/2018
1benzophenoneIBA
10/2015
17-epiclusianoneIBA
10/2015
1Temozolomide (Temodar)FDA LinkGeneric
12/2013
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
09/2013
15- (5,6- dimethoxy- 1H- benzimidazol- 1- yl)- 3- ((2- (trifluoromethyl)benzyl)oxy)thiophene- 2- carboxamideIBA
07/2013
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
05/2013

Therapy/Procedure

3Therapeutics
10/2020 - 11/2018
2Drug Therapy (Chemotherapy)
10/2020 - 02/2011
1Neoadjuvant Therapy
07/2013
1Aftercare (After-Treatment)
12/2012